“Transparency” scheme : what’s new ?
As a reminder, the "Transparency" scheme, provided for in Articles L. 1453-1 et seq. and R. 1453-4 of the French…
Chambers Guide – Pharmaceutical Advertising
Under which conditions is medicinal product advertising authorized in France? Is the advertising of medicinal products benefiting from derogatory access,…
Minimum safety stock increased to 4 months for 422 medicinal products of major therapeutic interest
The ANSM has just published the list of medicinal products of major therapeutic interest (MITM) that must be subject to…
The quality charter for the professional practices of persons responsible for the presentation, information or promotion of MD is published
Article L. 162-17-9 of the Social Security Code, created by the LFSS for 2018, provides - in the same spirit…
Security of supply : what we learn from the annual report of the court of auditors
The Court of Auditors[1]published yesterday its annual report for 2022, in which a chapter is devoted to the security of…
Assessement of the financial penalties imposed by ANSM in 2021
Six financial penalties were imposed by the ANSM in 2021 in relation to health products for an amount of €508,048,…